BMS-309403 sodium - ≥99% , CAS No.2802523-05-1

CAS: 2802523-05-1 Cat. No.: B649312 Fórmula: C31H25N2NaO3 Peso molecular: 496.53
Disponible para pedir
CALIDAD & PUREZA ≥99%
Storage
Store at 2-8°C,Desiccated
Shipped In
Wet ice
★
Talla
USA
Alemania (EU)*
Precio
Cantidad
5mg
B649312-5mg
Fabricado bajo pedido · 8–12 semanas
110,90US$
10mg
B649312-10mg
Fabricado bajo pedido · 8–12 semanas
200,90US$
25mg
B649312-25mg
Fabricado bajo pedido · 8–12 semanas
400,90US$
50mg
B649312-50mg
Fabricado bajo pedido · 8–12 semanas
640,90US$
100mg
B649312-100mg
Fabricado bajo pedido · 8–12 semanas
1.020,90US$
Enter a quantity for the sizes you want to add.

Descripción general

BMS-309403 sodium is a potent, orally active, and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor, with K i s of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 sodium interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 sodium improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .

In Vitro

Treatment with BMS-309403 significantly decreased MCP-1 production from THP-1 macrophages in a dose- and time-dependent manner. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

BMS-309403 sodium (15 mg/kg; chronic treatment; daily for 6 weeks) improves endothelial function, phosphorylated and total eNOS and reduced plasma triglyceride levels but did not affect endothelium-independent relaxations. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: C57BL/6J mice (ApoE −/− mice)Dosage: 15 mg/kg Administration: Chronic treatment ; daily for 6 weeks Result: Significantly increased the phosphorylated eNOS (Ser1177) and total eNOS but not the phosphorylated to total eNOS ratio in aortae of 18 weeks old ApoE −/− mice.

Form:Solid

Especificaciones

Especificaciones y pureza
≥99%
Mecanismos bioquímicos y fisiológicos
BMS-309403 sodium is a potent, orally active, and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor, with K i s of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 sodium interacts with the fatty-
Condiciones de almacenamiento de almacenamiento
Store at 2-8°C,Desiccated
Enviado en
Wet ice
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Tipo de acción
INHIBITOR
Pureza
≥99%
Nombres e identificadores
Peso molecular
496.53

Datos avanzados

Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Propiedades químicas y físicas
SolubilidadH2O : 100 mg/mL (201.40 mM; Need ultrasonic) DMSO : 50 mg/mL (100.70 mM; Need ultrasonic)
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Preguntas frecuentes

How is this product shipped?
This product ships chilled on wet ice. Unpack on arrival and transfer it to the storage condition stated above.

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.